Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disease Outbreaks | 11 | 2021 | 124 | 2.350 |
Why?
|
| Mumps | 5 | 2021 | 13 | 1.750 |
Why?
|
| Arkansas | 21 | 2024 | 1973 | 1.190 |
Why?
|
| Immunization Programs | 3 | 2016 | 21 | 1.030 |
Why?
|
| Mumps virus | 3 | 2021 | 11 | 0.960 |
Why?
|
| Histoplasmosis | 3 | 2018 | 50 | 0.930 |
Why?
|
| Wounds and Injuries | 1 | 2024 | 289 | 0.730 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2020 | 19 | 0.690 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2019 | 4 | 0.630 |
Why?
|
| School Health Services | 2 | 2016 | 49 | 0.590 |
Why?
|
| Sepsis | 1 | 2020 | 226 | 0.570 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2017 | 28 | 0.560 |
Why?
|
| Vaccination | 2 | 2019 | 277 | 0.560 |
Why?
|
| Lyme Disease | 1 | 2017 | 32 | 0.560 |
Why?
|
| Absenteeism | 1 | 2016 | 17 | 0.510 |
Why?
|
| Smallpox | 1 | 2015 | 3 | 0.490 |
Why?
|
| Smallpox Vaccine | 1 | 2015 | 2 | 0.490 |
Why?
|
| Immunity, Humoral | 1 | 2015 | 22 | 0.480 |
Why?
|
| Bambusa | 1 | 2014 | 2 | 0.450 |
Why?
|
| Fires | 1 | 2014 | 14 | 0.440 |
Why?
|
| Pertussis Vaccine | 1 | 2013 | 2 | 0.440 |
Why?
|
| Whooping Cough | 1 | 2013 | 13 | 0.430 |
Why?
|
| Communicable Disease Control | 1 | 2013 | 35 | 0.420 |
Why?
|
| Endemic Diseases | 2 | 2018 | 22 | 0.420 |
Why?
|
| Medical Informatics Applications | 1 | 2013 | 7 | 0.410 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 11 | 0.410 |
Why?
|
| Coccidioidomycosis | 1 | 2012 | 6 | 0.390 |
Why?
|
| Humans | 33 | 2024 | 50673 | 0.380 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 225 | 0.380 |
Why?
|
| Blastomycosis | 1 | 2012 | 62 | 0.370 |
Why?
|
| Neoplasms | 1 | 2020 | 1250 | 0.350 |
Why?
|
| Internet | 1 | 2013 | 262 | 0.340 |
Why?
|
| Child, Preschool | 7 | 2024 | 3965 | 0.340 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 3244 | 0.320 |
Why?
|
| Adolescent | 8 | 2024 | 6489 | 0.310 |
Why?
|
| Incidence | 4 | 2019 | 1036 | 0.290 |
Why?
|
| Male | 16 | 2024 | 25991 | 0.280 |
Why?
|
| Infant | 5 | 2024 | 3656 | 0.280 |
Why?
|
| Adult | 12 | 2024 | 13636 | 0.270 |
Why?
|
| Young Adult | 6 | 2024 | 4114 | 0.270 |
Why?
|
| Child | 7 | 2024 | 6976 | 0.260 |
Why?
|
| Middle Aged | 10 | 2024 | 12648 | 0.250 |
Why?
|
| Population Surveillance | 2 | 2018 | 164 | 0.250 |
Why?
|
| Female | 14 | 2024 | 27181 | 0.250 |
Why?
|
| Influenza, Human | 2 | 2016 | 86 | 0.230 |
Why?
|
| Environmental Exposure | 3 | 2001 | 201 | 0.210 |
Why?
|
| Aged | 7 | 2024 | 9770 | 0.210 |
Why?
|
| Hot Springs | 1 | 2022 | 1 | 0.190 |
Why?
|
| Legionella pneumophila | 1 | 2022 | 5 | 0.190 |
Why?
|
| Legionnaires' Disease | 1 | 2022 | 3 | 0.190 |
Why?
|
| Fishes | 2 | 2001 | 22 | 0.190 |
Why?
|
| Methotrexate | 1 | 2022 | 77 | 0.190 |
Why?
|
| Water Supply | 3 | 2022 | 21 | 0.190 |
Why?
|
| Pfiesteria piscicida | 1 | 2001 | 2 | 0.190 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2020 | 11 | 0.180 |
Why?
|
| Genotype | 2 | 2019 | 532 | 0.180 |
Why?
|
| Outpatients | 1 | 2020 | 121 | 0.160 |
Why?
|
| Serologic Tests | 1 | 2019 | 25 | 0.160 |
Why?
|
| Antibodies, Viral | 2 | 2019 | 95 | 0.160 |
Why?
|
| Burkholderia Infections | 1 | 2018 | 4 | 0.150 |
Why?
|
| Burkholderia | 1 | 2018 | 11 | 0.150 |
Why?
|
| Wound Infection | 1 | 2018 | 27 | 0.150 |
Why?
|
| Chagas Disease | 1 | 2018 | 3 | 0.150 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 180 | 0.150 |
Why?
|
| Histoplasma | 1 | 2018 | 27 | 0.150 |
Why?
|
| Emigrants and Immigrants | 1 | 2018 | 37 | 0.140 |
Why?
|
| Genome, Bacterial | 1 | 2018 | 125 | 0.140 |
Why?
|
| Babesiosis | 1 | 2017 | 6 | 0.140 |
Why?
|
| Public Health | 2 | 2019 | 199 | 0.140 |
Why?
|
| Water Wells | 1 | 2016 | 1 | 0.130 |
Why?
|
| Animals | 7 | 2024 | 13156 | 0.130 |
Why?
|
| Ticks | 1 | 2016 | 6 | 0.130 |
Why?
|
| Tick-Borne Diseases | 1 | 2016 | 4 | 0.130 |
Why?
|
| Droughts | 1 | 2016 | 9 | 0.130 |
Why?
|
| Ownership | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cause of Death | 1 | 1997 | 150 | 0.130 |
Why?
|
| Transients and Migrants | 1 | 2016 | 22 | 0.130 |
Why?
|
| Blood Transfusion | 1 | 2017 | 126 | 0.130 |
Why?
|
| Cryptococcosis | 1 | 2015 | 19 | 0.120 |
Why?
|
| Cryptococcus neoformans | 1 | 2015 | 27 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2016 | 131 | 0.120 |
Why?
|
| Medical Staff, Hospital | 1 | 2015 | 15 | 0.120 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2015 | 23 | 0.120 |
Why?
|
| Nursing Staff, Hospital | 1 | 2015 | 34 | 0.120 |
Why?
|
| Education, Medical, Continuing | 1 | 2015 | 70 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 31 | 0.120 |
Why?
|
| Regression Analysis | 1 | 2016 | 382 | 0.120 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2016 | 267 | 0.110 |
Why?
|
| Salmonella Food Poisoning | 1 | 2014 | 6 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2015 | 85 | 0.110 |
Why?
|
| Salmonella | 1 | 2014 | 26 | 0.110 |
Why?
|
| School Nursing | 1 | 2013 | 9 | 0.110 |
Why?
|
| Prisons | 1 | 2014 | 37 | 0.110 |
Why?
|
| Prostatic Neoplasms | 1 | 1997 | 385 | 0.110 |
Why?
|
| Health Personnel | 1 | 2015 | 251 | 0.100 |
Why?
|
| United States | 6 | 2022 | 5012 | 0.100 |
Why?
|
| Fish Diseases | 2 | 2001 | 6 | 0.080 |
Why?
|
| Genome, Viral | 2 | 2021 | 79 | 0.080 |
Why?
|
| Water Microbiology | 2 | 2022 | 29 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5294 | 0.070 |
Why?
|
| Phylogeny | 2 | 2019 | 237 | 0.070 |
Why?
|
| Hip Fractures | 1 | 2008 | 46 | 0.070 |
Why?
|
| Diarrhea | 2 | 2014 | 92 | 0.070 |
Why?
|
| Chickenpox Vaccine | 1 | 2006 | 5 | 0.070 |
Why?
|
| Chickenpox | 1 | 2006 | 18 | 0.060 |
Why?
|
| Social Support | 1 | 2008 | 264 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2014 | 1157 | 0.060 |
Why?
|
| Mortality | 2 | 2001 | 96 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2001 | 355 | 0.050 |
Why?
|
| Methylmercury Compounds | 1 | 2001 | 5 | 0.050 |
Why?
|
| Inhalation Exposure | 1 | 2001 | 31 | 0.050 |
Why?
|
| Pharyngitis | 1 | 2001 | 16 | 0.050 |
Why?
|
| Water | 1 | 2022 | 77 | 0.050 |
Why?
|
| Nausea | 1 | 2001 | 46 | 0.050 |
Why?
|
| Washington | 1 | 2021 | 46 | 0.050 |
Why?
|
| Headache | 1 | 2001 | 74 | 0.050 |
Why?
|
| Eye Diseases | 1 | 2001 | 34 | 0.050 |
Why?
|
| Aerosols | 1 | 2001 | 75 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 1613 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2001 | 83 | 0.040 |
Why?
|
| Micronesia | 1 | 2021 | 106 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2015 | 1455 | 0.040 |
Why?
|
| Cell Movement | 1 | 2001 | 245 | 0.040 |
Why?
|
| Biopsy | 1 | 2022 | 589 | 0.040 |
Why?
|
| Occupational Exposure | 1 | 2001 | 113 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 229 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2755 | 0.040 |
Why?
|
| Mumps Vaccine | 1 | 2019 | 6 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2019 | 21 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 63 | 0.040 |
Why?
|
| Multilocus Sequence Typing | 1 | 2018 | 14 | 0.040 |
Why?
|
| Trypanosoma cruzi | 1 | 2018 | 2 | 0.040 |
Why?
|
| Bacterial Typing Techniques | 1 | 2018 | 40 | 0.040 |
Why?
|
| Latin America | 1 | 2018 | 9 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 17 | 0.040 |
Why?
|
| Amnesia | 1 | 1998 | 8 | 0.040 |
Why?
|
| Dinoflagellida | 1 | 1998 | 5 | 0.040 |
Why?
|
| Geography, Medical | 1 | 2018 | 5 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2018 | 13 | 0.040 |
Why?
|
| Neurons | 1 | 2001 | 452 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2018 | 57 | 0.040 |
Why?
|
| Quinine | 1 | 2017 | 5 | 0.040 |
Why?
|
| Babesia | 1 | 2017 | 5 | 0.040 |
Why?
|
| Clindamycin | 1 | 2017 | 14 | 0.030 |
Why?
|
| Wisconsin | 1 | 1997 | 44 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 2017 | 29 | 0.030 |
Why?
|
| Doxycycline | 1 | 2017 | 34 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 197 | 0.030 |
Why?
|
| Liver | 1 | 2022 | 1133 | 0.030 |
Why?
|
| Water Quality | 1 | 2016 | 8 | 0.030 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 216 | 0.030 |
Why?
|
| Risk Factors | 3 | 2015 | 3731 | 0.030 |
Why?
|
| Bird Diseases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Birds | 1 | 2015 | 12 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 2015 | 19 | 0.030 |
Why?
|
| Uridine Monophosphate | 1 | 2015 | 3 | 0.030 |
Why?
|
| Hepatitis C Antibodies | 1 | 2015 | 19 | 0.030 |
Why?
|
| Ribavirin | 1 | 2015 | 14 | 0.030 |
Why?
|
| Focus Groups | 1 | 2016 | 195 | 0.030 |
Why?
|
| Drug Costs | 1 | 2015 | 39 | 0.030 |
Why?
|
| Food Handling | 1 | 2014 | 16 | 0.030 |
Why?
|
| Serotyping | 1 | 2014 | 13 | 0.030 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 29 | 0.030 |
Why?
|
| Food Contamination | 1 | 2014 | 37 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2015 | 228 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2015 | 171 | 0.030 |
Why?
|
| Hospitalization | 1 | 2018 | 677 | 0.030 |
Why?
|
| Feces | 1 | 2014 | 138 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 929 | 0.020 |
Why?
|
| Maryland | 2 | 2001 | 32 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2015 | 6294 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2008 | 2395 | 0.020 |
Why?
|
| Baltimore | 1 | 2008 | 26 | 0.020 |
Why?
|
| Friends | 1 | 2008 | 20 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2008 | 416 | 0.020 |
Why?
|
| Family | 1 | 2008 | 177 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 584 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 907 | 0.020 |
Why?
|
| Schools | 1 | 2006 | 164 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2001 | 12 | 0.010 |
Why?
|
| Virginia | 1 | 2001 | 19 | 0.010 |
Why?
|
| Fisheries | 1 | 2001 | 8 | 0.010 |
Why?
|
| North Carolina | 1 | 2001 | 57 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2001 | 105 | 0.010 |
Why?
|
| Ecosystem | 1 | 2001 | 64 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2001 | 207 | 0.010 |
Why?
|
| Cerebellum | 1 | 2001 | 133 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 362 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 191 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 197 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 570 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2001 | 261 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2001 | 246 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 393 | 0.010 |
Why?
|
| Hotlines | 1 | 1998 | 16 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 1089 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1578 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2001 | 1271 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2001 | 1618 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 5677 | 0.010 |
Why?
|